V Meininger
Overview
Explore the profile of V Meininger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
2858
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Corcia P, Couratier P, Blasco H, Andres C, Beltran S, Meininger V, et al.
Rev Neurol (Paris)
. 2017 Apr;
173(5):254-262.
PMID: 28449881
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease characterized by upper and lower motor neuron damage in the bulbar and spinal territories. Although the pathophysiology of ALS is...
2.
Blasco H, Patin F, Molinier S, Vourch P, Le Tilly O, Bakkouche S, et al.
Eur J Clin Nutr
. 2017 Apr;
71(9):1133-1135.
PMID: 28422121
Although the global benefits of gastrostomy have been proven in amyotrophic lateral sclerosis (ALS), the impact on biological parameters has not been explored yet. The aim of this preliminary work...
3.
Corcia P, Beltran S, Vourch P, Meininger V, Couratier P
Rev Neurol (Paris)
. 2015 Nov;
171(11):747-9.
PMID: 26573965
No abstract available.
4.
Lenglet T, Lacomblez L, Abitbol J, Ludolph A, Mora J, Robberecht W, et al.
Eur J Neurol
. 2014 Jan;
21(3):529-36.
PMID: 24447620
Background And Purpose: To assess the efficacy and safety of olesoxime, a molecule with neuroprotective properties, in patients with amyotrophic lateral sclerosis (ALS) treated with riluzole. Methods: A double-blind, randomized,...
5.
Cordesse V, Jametal T, Guy C, Lefebvre S, Roussel M, Ruggeri J, et al.
Rev Neurol (Paris)
. 2013 Apr;
169(6-7):476-84.
PMID: 23623808
Neurological diseases are characterized by the complexity of care and by a constant and changing disability. More and more frequently, their impact on the clinical pathway remains unknown. Seven postgraduate...
6.
Corcia P, Valdmanis P, Millecamps S, Lionnet C, Blasco H, Mouzat K, et al.
Neurology
. 2012 Apr;
78(19):1519-26.
PMID: 22539580
Objective: To describe the phenotype and phenotype-genotype correlations in patients with amyotrophic lateral sclerosis (ALS) with TARDBP gene mutations. Methods: French TARDBP+ patients with ALS (n = 28) were compared...
7.
Fraidakis M, Drunat S, Maisonobe T, Gerard B, Pradat P, Meininger V, et al.
Neurology
. 2012 Feb;
78(8):551-6.
PMID: 22323744
Objective: We report the cases of 2 patients with late-onset spinal muscular atrophy (SMA) type III, who were hemizygous for SMN1 deletion and carriers of novel SMN1 intragenic missense mutations,...
8.
Aebischer J, Moumen A, Sazdovitch V, Seilhean D, Meininger V, Raoul C
Eur J Neurol
. 2012 Jan;
19(5):752-9, e45-6.
PMID: 22221541
Background: Amyotrophic lateral sclerosis (ALS) is a paralytic and fatal neurodegenerative disorder caused by the gradual loss of both upper and lower motoneurons. There is compelling evidence from ALS experimental...
9.
Bensimon G, Lacomblez L, Meininger V, Valery C, Klatzman D
Restor Neurol Neurosci
. 2011 May;
8(1):73-4.
PMID: 21551811
No abstract available.
10.
Aebischer J, Cassina P, Otsmane B, Moumen A, Seilhean D, Meininger V, et al.
Cell Death Differ
. 2010 Nov;
18(5):754-68.
PMID: 21072055
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that primarily affects motoneurons in the brain and spinal cord. Dominant mutations in superoxide dismutase-1 (SOD1) cause a familial form of...